Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire
NCT ID: NCT06523192
Last Updated: 2024-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
146 participants
OBSERVATIONAL
2023-03-21
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This research project is part of an MSc in Allergy undertaken by the principal applicant, Dr Patricia Romero, supervised through Imperial College London.
Target population are patients with a drug allergy diagnosed by an Allergist prospectively at the Drug Allergy Clinic.
Is the English version of the Drug Hypersensitivity Quality of Life Questionnaire suitable to be used in the UK population?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Allergy UK Research and Development Nurse Project
NCT03826953
VALIDATION OF THE CHAPTER "ALLERGIES AND HYPERSENSITIVITY" OF THE INTERNATIONAL DISEASE CLASSIFICATION (CIM)
NCT03213808
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917
Quality of Life of Patients With a History of Drug Allergy in Thailand
NCT01666470
Safety Study of Levocetirizine and Fexofenadine
NCT01586091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to read English and consent.
* Confirmed diagnosis of a drug hypersensitivity reaction.
* Written informed consent
Exclusion Criteria
* Not able to read English. No mental capacity to consent or unwilling to consent.
* Unconfirmed diagnosis of a drug hypersensitivity reaction.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospitals, Leicester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UNiversity Hospitals Leicester
Leicester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
151058
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.